TY  - CONF

T1  - Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

JO  - JNCI Journal of the National Cancer Institute

PY  - 2004/11/17

AU  - Vasey PA

AU  - Jayson GC

AU  - Gordon A

AU  - Gabra H

AU  - Coleman R

AU  - Atkinson R

AU  - Parkin D

AU  - Paul J

AU  - Hay A

AU  - Kaye SB

ED  - 

DO  - DOI: 10.1093/jnci/djh323

PB  - Oxford University Press (OUP)

VL  - 96

IS  - 22

SP  - 1682

EP  - 1691

Y2  - 2025/10/10

ER  -